We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.00 | - |
By Cecilia Butini
Bayer booked impairments and charges related to its agricultural business, where lower glyphosate prices weighed, leading to a widened second-quarter loss, it said Tuesday.
The German pharmaceutical and agricultural company said impairment losses of 2.30 billion euros ($2.53 billion) dragged earnings, and posted a net loss for the quarter of EUR1.88 billion. In the same quarter the previous year, the net loss had been EUR298 million.
Sales were EUR11.04 billion for the period, in line with a forecast the company gave when it revised its guidance on July 24. Earnings before interest, taxes, depreciation and amortization before special items--a key company metric--declined to EUR2.53 billion from EUR3.35 billion the previous year, in line with company expectations.
Bayer confirmed the lowered guidance it issued on July 24 due to a significant decline in sales of glyphosate-based products. The guidance includes projected sales in a range of EUR48.5 billion and EUR49.5 billion for the full year, meaning a 2% to 3% decline.
The Crop Science agricultural division is seen with a sales decline of 5%, while sales in the pharmaceutical business are expected roughly flat compared with the previous year, Bayer said.
Write to Cecilia Butini at cecilia.butini@wsj.com
(END) Dow Jones Newswires
August 08, 2023 02:28 ET (06:28 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year Bayer Chart |
1 Month Bayer Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions